Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

Recent studies suggest that extracorporeal photochemotherapy (ECP) may be beneficial in
patients with steroid‐refractory chronic graft‐versus‐host disease (cGvHD). However, it is …

BACKGROUND: Chronic graft‐versus‐host disease (cGVHD) classification has recently
been improved by the National Institutes of Health (NIH); patients' stratification with those …

Although significant advances have been made in the biologic understanding of graft-versus-
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …

Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host
disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy,
has previously demonstrated promising results in treating chronic graft-versus-host disease …

BACKGROUND: Extracorporeal photochemotherapy (ECP) is a valid therapeutic option in
the treatment of acute and chronic graft‐versus‐host disease (aGVHD and cGVHD …